{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:31:03Z","timestamp":1789047063868,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Taiwan Health Foundation","award":["THF 2024001"],"award-info":[{"award-number":["THF 2024001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11695-026-08876-y","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:58:15Z","timestamp":1784786295000},"page":"4801-4810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth Differentiation Factor 15 and Histology-Defined Steatohepatitis and Fibrosis in Severe Obesity Undergoing Bariatric Surgery"],"prefix":"10.1007","volume":"36","author":[{"given":"Young-Jen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Huei","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shiung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Nien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tsan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"4","key":"8876_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"10464","key":"8876_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, et al. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"issue":"6","key":"8876_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","volume":"38","author":"JH Hong","year":"2014","unstructured":"Hong JH, Chung HK, Park HY, et al. GDF15 Is a Novel Biomarker for Impaired Fasting Glucose. Diabetes Metab J. 2014;38(6):472\u20139.","journal-title":"Diabetes Metab J"},{"issue":"7795","key":"8876_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll AP, Chen M, Taskar P, et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature. 2020;578(7795):444\u20138.","journal-title":"Nature"},{"issue":"4","key":"8876_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/liv.13587","volume":"38","author":"BK Koo","year":"2018","unstructured":"Koo BK, Um SH, Seo DS, et al. Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease. Liver Int. 2018;38(4):695\u2013705.","journal-title":"Liver Int"},{"key":"8876_CR6","doi-asserted-by":"crossref","unstructured":"Lai M, Dillon ST, Gu X et al. Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis. Hepatol Commun. 2024;8(12):e0586.","DOI":"10.1097\/HC9.0000000000000586"},{"issue":"Suppl 1","key":"8876_CR7","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice C. 2","year":"2024","unstructured":"American Diabetes Association Professional Practice C. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"6","key":"8876_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"2","key":"8876_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"4","key":"8876_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u201354.","journal-title":"Hepatology"},{"issue":"1","key":"8876_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","volume":"93","author":"SG Sheth","year":"1998","unstructured":"Sheth SG, Flamm SL, Gordon FD, et al. AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93(1):44\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"8876_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"issue":"5","key":"8876_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, et al. Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology. 2024;79(5):1212\u20139.","journal-title":"Hepatology"},{"issue":"7","key":"8876_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic Dysfunction-Associated Steatotic Liver Disease. N Engl J Med. 2025;393(7):683\u201398.","journal-title":"N Engl J Med"},{"issue":"4","key":"8876_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598\u2013607.","journal-title":"J Hepatol"},{"key":"8876_CR16","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.arr.2022.101569","volume":"75","author":"M Conte","year":"2022","unstructured":"Conte M, Giuliani C, Chiariello A, et al. GDF15, an emerging key player in human aging. Ageing Res Rev. 2022;75:101569.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"8876_CR17","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","volume":"60","author":"P Welsh","year":"2022","unstructured":"Welsh P, Kimenai DM, Marioni RE, et al. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort. Clin Chem Lab Med. 2022;60(11):1820\u20139.","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"8876_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang D, Day EA, Townsend LK, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol. 2021;17(10):592\u2013607.","journal-title":"Nat Rev Endocrinol"},{"key":"8876_CR19","doi-asserted-by":"publisher","first-page":"111820","DOI":"10.1016\/j.diabres.2024.111820","volume":"217","author":"S Colosimo","year":"2024","unstructured":"Colosimo S, Miller H, Koutoukidis DA, et al. Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD. Diabetes Res Clin Pract. 2024;217:111820.","journal-title":"Diabetes Res Clin Pract"},{"key":"8876_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4137\/BMI.S38440","volume":"11","author":"SI Sherwani","year":"2016","unstructured":"Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95\u2013104.","journal-title":"Biomark Insights"},{"issue":"5","key":"8876_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/EJE-12-0466","volume":"167","author":"T Kempf","year":"2012","unstructured":"Kempf T, Guba-Quint A, Torgerson J, et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol. 2012;167(5):671\u20138.","journal-title":"Eur J Endocrinol"},{"key":"8876_CR22","doi-asserted-by":"publisher","first-page":"8278039","DOI":"10.1155\/2018\/8278039","volume":"2018","author":"Y Kim","year":"2018","unstructured":"Kim Y, Noren Hooten N, Evans MK. CRP Stimulates GDF15 Expression in Endothelial Cells through p53. Mediators Inflamm. 2018;2018:8278039.","journal-title":"Mediators Inflamm"},{"issue":"10","key":"8876_CR23","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","volume":"20","author":"EC Hsiao","year":"2000","unstructured":"Hsiao EC, Koniaris LG, Zimmers-Koniaris T, et al. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol. 2000;20(10):3742\u201351.","journal-title":"Mol Cell Biol"},{"issue":"26","key":"8876_CR24","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855\u20139.","journal-title":"N Engl J Med"},{"key":"8876_CR25","doi-asserted-by":"crossref","unstructured":"Liu CJ, Chen PJ. Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead. Viruses. 2020;12(8):815.","DOI":"10.3390\/v12080815"},{"issue":"4","key":"8876_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"6","key":"8876_CR27","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s10620-021-07009-y","volume":"67","author":"MH Lin","year":"2022","unstructured":"Lin MH, Li HQ, Zhu L, et al. Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis. Dig Dis Sci. 2022;67(6):2608\u201326.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"8876_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1530\/EJE-09-1066","volume":"162","author":"M Carstensen","year":"2010","unstructured":"Carstensen M, Herder C, Brunner EJ, et al. Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study. Eur J Endocrinol. 2010;162(5):913\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"8876_CR29","doi-asserted-by":"publisher","first-page":"F1249","DOI":"10.1152\/ajprenal.00387.2013","volume":"305","author":"M Mazagova","year":"2013","unstructured":"Mazagova M, Buikema H, van Buiten A, et al. Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes. Am J Physiol Ren Physiol. 2013;305(9):F1249\u201364.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"8876_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12020-023-03377-9","volume":"81","author":"P Iglesias","year":"2023","unstructured":"Iglesias P, Silvestre RA, Diez JJ. Growth differentiation factor 15 (GDF-15) in endocrinology. Endocrine. 2023;81(3):419\u201331.","journal-title":"Endocrine"},{"issue":"3","key":"8876_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2017.08.096","volume":"498","author":"D Li","year":"2018","unstructured":"Li D, Zhang H, Zhong Y. Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice. Biochem Biophys Res Commun. 2018;498(3):388\u201394.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"8876_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41387-022-00187-2","volume":"12","author":"B Galuppo","year":"2022","unstructured":"Galuppo B, Agazzi C, Pierpont B, et al. Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity. Nutr Diabetes. 2022;12(1):9.","journal-title":"Nutr Diabetes"},{"key":"8876_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"8876_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, et al. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease in Adults: A Review. JAMA. 2026;335(2):163\u201374.","journal-title":"JAMA"},{"issue":"1","key":"8876_CR35","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1038\/s41598-018-25098-0","volume":"8","author":"KH Kim","year":"2018","unstructured":"Kim KH, Kim SH, Han DH, et al. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Sci Rep. 2018;8(1):6789.","journal-title":"Sci Rep"},{"issue":"1","key":"8876_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung HK, Ryu D, Kim KS, et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J Cell Biol. 2017;216(1):149\u201365.","journal-title":"J Cell Biol"},{"issue":"5","key":"8876_CR37","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1111\/dom.16233","volume":"27","author":"H Wang","year":"2025","unstructured":"Wang H, Xu X, Shi L, et al. Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction-associated steatohepatitis: A nested case-control study of UK Biobank proteomic data. Diabetes Obes Metab. 2025;27(5):2387\u201396.","journal-title":"Diabetes Obes Metab"},{"key":"8876_CR38","doi-asserted-by":"publisher","first-page":"155237","DOI":"10.1016\/j.metabol.2022.155237","volume":"133","author":"L Valenzuela-Vallejo","year":"2022","unstructured":"Valenzuela-Vallejo L, Chrysafi P, Bello-Ramos J, et al. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism. 2022;133:155237.","journal-title":"Metabolism"},{"issue":"5","key":"8876_CR39","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","volume":"178","author":"HH Luan","year":"2019","unstructured":"Luan HH, Wang A, Hilliard BK, et al. GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell. 2019;178(5):1231\u2013e4411.","journal-title":"Cell"},{"issue":"1","key":"8876_CR40","doi-asserted-by":"publisher","first-page":"27527","DOI":"10.1038\/s41598-024-77719-6","volume":"14","author":"JS Chang","year":"2024","unstructured":"Chang JS, Ahn JH, Kim MY, et al. Elevated serum growth differentiation factor 15 and decorin predict the fibrotic progression of metabolic dysfunction-associated steatotic liver disease. Sci Rep. 2024;14(1):27527.","journal-title":"Sci Rep"},{"issue":"1","key":"8876_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41387-021-00170-3","volume":"11","author":"J Bilson","year":"2021","unstructured":"Bilson J, Scorletti E, Bindels LB, et al. Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutr Diabetes. 2021;11(1):32.","journal-title":"Nutr Diabetes"},{"issue":"4","key":"8876_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/hepr.14148","volume":"55","author":"MP Werge","year":"2025","unstructured":"Werge MP, Grandt J, Thing M, et al. Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease. Hepatol Res. 2025;55(4):492\u2013504.","journal-title":"Hepatol Res"},{"issue":"5","key":"8876_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcmgh.2023.07.009","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Huai Q, Zhu C, et al. GDF15 Ameliorates Liver Fibrosis by Metabolic Reprogramming of Macrophages to Acquire Anti-Inflammatory Properties. Cell Mol Gastroenterol Hepatol. 2023;16(5):711\u201334.","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08876-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:54:41Z","timestamp":1789044881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8876"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08876-y","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}